These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 8839956

  • 21. Neuroleptic malignant syndrome with risperidone.
    Levin GM, Lazowick AL, Powell HS.
    J Clin Psychopharmacol; 1996 Apr; 16(2):192-3. PubMed ID: 8690838
    [No Abstract] [Full Text] [Related]

  • 22. Risperidone-induced hyperamylasemia, hyperlipasemia, and neuroleptic malignant syndrome: a case report.
    Ghio L, Fornaro G, Rossi P.
    J Clin Psychopharmacol; 2009 Aug; 29(4):391-2. PubMed ID: 19593182
    [No Abstract] [Full Text] [Related]

  • 23. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S, Kornreich C, Choubani Z, Gourevitch R.
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Neuroleptic malignant syndrome in users of risperidone].
    Bonte-Mineur F, Geerlings CJ, Rietveld AP.
    Ned Tijdschr Geneeskd; 2005 Jan 15; 149(3):158-9; author reply 159. PubMed ID: 15693595
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Comment: neuroleptic malignant syndrome associated with risperidone and fluvoxamine.
    Isbister GK, Dawson AH, Whyte IM.
    Ann Pharmacother; 2002 Jan 15; 36(7-8):1293; author reply 1294. PubMed ID: 12086569
    [No Abstract] [Full Text] [Related]

  • 38. Neuroleptic malignant-like syndrome induced with low-dose quetiapine treated with electroconvulsive therapy.
    Bora E, Saffet Gonul A, Akdeniz F, Vahip S.
    Eur Psychiatry; 2003 Oct 15; 18(6):323. PubMed ID: 14611931
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Neuroleptic malignant syndrome and acute life-threatening catatonia--two contrasting disease entities?].
    Heils A, Lesch KP.
    Fortschr Neurol Psychiatr; 1997 Jan 15; 65(1):8-15. PubMed ID: 9132369
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.